Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
By Health, Human Services Department, National Institutes of Health · Nov 1, 2026, 11:00 PM CST
The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to AntaraCore, Systems, Inc., located in Dover, Delaware, to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice.
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisNeutral factual statementThe language is straightforward and devoid of persuasive or emotive framing, typical of an official agency notice.
Context
AI analysisMissing context
The notice does not provide details about the specific patent applications, the criteria used by NHLBI to evaluate the license, the intended commercial or research use of the licensed technology, or any timeline for the decision.
Important context
The announcement is an official notice from a federal health agency (NHLBI, NIH, HHS) regarding a potential exclusive licensing arrangement, which is a standard procedural step in technology transfer for federally funded research.
Opinion vs. reporting
AI analysisThe document is a factual notice; it contains no opinion, only a statement of contemplated action.